XOMA
NASDAQ · Biotechnology
Xoma Royalty Corporation
$30.61
+1.39 (+4.76%)
Open$29.48
Previous Close$29.22
Day High$30.95
Day Low$29.36
52W High$39.92
52W Low$18.35
Volume—
Avg Volume124.8K
Market Cap324.01M
P/E Ratio14.97
EPS$1.09
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
+30.7% upside
Current
$30.61
$30.61
Target
$40.02
$40.02
$30.13
$40.02 avg
$66.99
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 30.26M | 33.35M | 45.56M |
| Net Income | -14,680,390 | -14,563,878 | -2,452,418 |
| Profit Margin | -48.5% | -46.1% | -5.4% |
| EBITDA | -21,410,352 | -22,420,452 | -2,902,540 |
| Free Cash Flow | — | — | -1,967,070 |
| Rev Growth | -9.3% | -9.3% | +14.7% |
| Debt/Equity | 1.44 | 1.44 | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |